Article

AAO requiring proof of COVID-19 vaccination for annual meeting attendees

Author(s):

The American Academy of Ophthalmology issued a guidance this week requiring all in-person attendees at its annual meeting Nov. 12-15 in New Orleans to show proof of COVID-19 vaccination.

AAO requiring proof of COVID-19 vaccination for annual meeting attendees

The American Academy of Ophthalmology (AAO) will require all registrants attending its annual meeting to provide proof of vaccination.

AAO will hold its 2021 annual meeting Nov. 12-15 in New Orleans, La. The organization’s Board of Trustees determined that proof of COVID-19 vaccination would be necessary for everyone attending the annual meeting.

“Every AAO 2021 attendee, all Academy staff, exhibitors and guests will be required to show proof of vaccination before being allowed to enter the convention center,” AAO said in a guidance released on its website.

Prior to arriving on site, attendees will be asked to provide proof that they are fully vaccinated with a vaccine approved by the U.S. Food and Drug Administration (FDA) or the World Health Organization (WHO).

According to the AAO, accepted vaccinations include Pfizer-BioNTech, Johnson and Johnson’s Janssen, Moderna, AstraZeneca-Oxford, and Sinopharm.

AAO will work with a third-party vendor to manage the verification of vaccination records, with instructions provided to pre-registrants on how to verify their vaccination status by Sept.15.

If attendees arrive at the convention center without having completed vaccine verification, it could result in delays while the AAO verifies information.

Unvaccinated attendees can register for the virtual option. Anyone who is registered and would like to switch to virtual attendance can email a written request to registration@aao.org by Oct. 29.

AAO is defining “fully vaccinated” as receiving your final dose two weeks before Nov. 10. This would include the second dose in a 2-dose series, such as with the Pfizer or Moderna vaccines, or the one shot of a single-dose vaccine such as with Johnson & Johnson's Janssen vaccine.

Anyone who is not fully vaccinated by the Nov. 10 deadline can switch to the virtual meeting option. The deadline to make that switch without penalty is also Oct. 29.

The academy also is encouraging all attendees to wear masks, regardless of any local man dates. Attendees also will be required to wear a mask on the meeting shuttle buses due to a mask mandate on all forms of public transportation by the U.S. Department of Transportation.

AAO also noted that there will be a number of onsite safety measures in place during the event, with all meeting rooms set up to allow for social distancing.

The convention center and AV staff will be cleaning all meeting rooms between sessions, including chairs, tables, podium and microphones.

Throughout the conference center, hand sanitizing stations will be available for attendees. Whenever possible, food and beverage will be served individually packaged.

Rapid COVID-19 testing also will be available in the convention center for anyone who may experience symptoms and for travelers who must show proof of a recent negative COVID-19 test for their return flights.

AAO also urges international attendees to check current travel restrictions to the United States on the Centers for Disease Control and Prevention website before making any travel plans.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.